Literature DB >> 24984798

A macrophage-stimulating compound from a screen of microbial natural products.

Julie A Perry1, Kalinka Koteva1, Chris P Verschoor2, Wenliang Wang1, Dawn M E Bowdish2, Gerry D Wright3.   

Abstract

Rising rates of antibiotic resistance in bacterial pathogens is a medical crisis of global concern that necessitates the development of new treatment strategies. We have isolated a natural product with macrophage-stimulating activity from a screen of microbially produced bioactive molecules. Streptazolin increased bacterial killing and elaboration of immunostimulatory cytokines by macrophages in vitro. Furthermore, we show that streptazolin stimulates the macrophage nuclear factor κB (NF-κB) pathway via phosphatidylinositide 3-kinase (PI3K) signaling, and that the conjugated diene moiety is essential for stimulatory activity. Immunostimulatory molecules like streptazolin represent entries into new treatment paradigms to address the challenge of antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24984798     DOI: 10.1038/ja.2014.83

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  22 in total

1.  Conagenin derived from Streptomyces roseosporus enhances macrophage functions.

Authors:  M Hamada; E Sonotake; S Yamamoto; S Moriguchi
Journal:  J Antibiot (Tokyo)       Date:  1999-06       Impact factor: 2.649

2.  Isolation and biological activity of a novel cytokine modulator, cytoxazone.

Authors:  H Kakeya; M Morishita; K Kobinata; M Osono; M Ishizuka; H Osada
Journal:  J Antibiot (Tokyo)       Date:  1998-12       Impact factor: 2.649

3.  Secondary metabolites by chemical screening. 4. Detection, isolation and biological activities of chiral synthons from Streptomyces.

Authors:  S Grabley; P Hammann; H Kluge; J Wink; P Kricke; A Zeeck
Journal:  J Antibiot (Tokyo)       Date:  1991-07       Impact factor: 2.649

4.  Esperamicins, a novel class of potent antitumor antibiotics. I. Physico-chemical data and partial structure.

Authors:  M Konishi; H Ohkuma; K Saitoh; H Kawaguchi; J Golik; G Dubay; G Groenewold; B Krishnan; T W Doyle
Journal:  J Antibiot (Tokyo)       Date:  1985-11       Impact factor: 2.649

5.  Phagocytic entry of Legionella pneumophila into macrophages through phosphatidylinositol 3,4,5-trisphosphate-independent pathway.

Authors:  Toshihiko Harada; Takashi Tanikawa; Yasunori Iwasaki; Masao Yamada; Yasuyuki Imai; Masaki Miyake
Journal:  Biol Pharm Bull       Date:  2012       Impact factor: 2.233

6.  Streptazones A, B(1), B(2), C, and D: new piperidine alkaloids from streptomycetes.

Authors:  C Puder; P Krastel; A Zeeck
Journal:  J Nat Prod       Date:  2000-09       Impact factor: 4.050

7.  New co-metabolites of the streptazolin pathway.

Authors:  C Puder; S Loya; A Hizi; A Zeeck
Journal:  J Nat Prod       Date:  2001-01       Impact factor: 4.050

8.  Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove.

Authors:  N Ikemoto; R A Kumar; T T Ling; G A Ellestad; S J Danishefsky; D J Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Stimulatory effect of forphenicinol on normal human bone marrow granulocyte-macrophage progenitor cells mediated by T-lymphocytes.

Authors:  N Ohhara; S Okamura; T Otsuka; M Harada; Y Niho
Journal:  Biomed Pharmacother       Date:  1987       Impact factor: 6.529

Review 10.  MKP-1: a critical phosphatase in the biology of macrophages controlling the switch between proliferation and activation.

Authors:  Mònica Comalada; Jorge Lloberas; Antonio Celada
Journal:  Eur J Immunol       Date:  2012-08       Impact factor: 5.532

View more
  5 in total

1.  Macrophage P2X4 receptors augment bacterial killing and protect against sepsis.

Authors:  Balázs Csóka; Zoltán H Németh; Ildikó Szabó; Daryl L Davies; Zoltán V Varga; János Pálóczi; Simonetta Falzoni; Francesco Di Virgilio; Rieko Muramatsu; Toshihide Yamashita; Pál Pacher; György Haskó
Journal:  JCI Insight       Date:  2018-06-07

2.  The streptazolin- and obscurolide-type metabolites from soil-derived Streptomyces alboniger YIM20533 and the mechanism of influence of γ-butyrolactone on the growth of Streptomyces by their non-enzymatic reaction biosynthesis.

Authors:  Na Luo; Ya-Bin Yang; Xue-Qiong Yang; Cui-Ping Miao; Yi-Qing Li; Li-Hua Xu; Zhong-Tao Ding; Li-Xing Zhao
Journal:  RSC Adv       Date:  2018-10-12       Impact factor: 4.036

3.  Challenges and Opportunities of Nontraditional Approaches to Treating Bacterial Infections.

Authors:  Brian N Tse; Amesh A Adalja; Christopher Houchens; Joseph Larsen; Thomas V Inglesby; Richard Hatchett
Journal:  Clin Infect Dis       Date:  2017-08-01       Impact factor: 9.079

Review 4.  Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.

Authors:  Yuan Liu; Ziwen Tong; Jingru Shi; Ruichao Li; Mathew Upton; Zhiqiang Wang
Journal:  Theranostics       Date:  2021-03-04       Impact factor: 11.556

Review 5.  Multitarget Approaches against Multiresistant Superbugs.

Authors:  Declan Alan Gray; Michaela Wenzel
Journal:  ACS Infect Dis       Date:  2020-03-19       Impact factor: 5.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.